BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.55
-0.10 (-1.77%)
At close: Nov 13, 2026, 4:00 PM EST
5.37
-0.18 (-3.32%)
After-hours: Nov 13, 2026, 7:53 PM EST
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $255.07 million as of November 13, 2026. It is the 19,002nd most valuable company in the world and the 3,320th biggest in the United States. Its market cap has decreased by 11.19% in one year.
Market Cap
255.07M
Enterprise Value
-94.52M
1-Year Change
-11.19%
Global Rank
Country Rank
#3,320 United States
Category
ChartMarket Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $255.07M, a decrease of -58.53%. That is a compound annual growth rate of -33.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 255.07M | -46.23% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 449.96M |
| Tilray Brands | 382.79M |
| Aurora Cannabis | 333.77M |
| Emergent BioSolutions | 310.55M |
| Canopy Growth | 261.40M |
| Lifecore Biomedical | 242.60M |
| SIGA Technologies | 225.62M |
| ADC Therapeutics | 225.06M |